Companies

Arena Pharmaceuticals, Inc.

NASDAQ: ARNA
$99.99
â–² $0.00 (+0.00%) today
Markets closed · 6:50pm ET

ARNA Coverage

Page 5
2:25pm ET
Health and Healthcare

Trader Watch: Will Arena Raise More Capital Now?

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is surging after the FDA approved its weight loss pill called BELVIQ.  In fact, now that shares have reopened after having been halted this stock is up…

Jon C. Ogg
11:02am ET
Investing

Today’s Breakout Stocks: High And Low

For today’s winners and losers, two of the four companies on the lists today are pharmaceutical companies, moving on action from drug regulators. One of them, Arena Pharmaceuticals, has seen its stock…

Douglas A. McIntyre
4:05pm ET
Investing

24/7 Wall St. Closing Bell

The major US stock indexes opened significantly lower this morning as investors reacted to the surprise loss of $2 billion by JPMorgan Chase & Co. (NYSE: JPM) disclosed by the bank’s CEO…

Paul Ausick
6:50am ET
Media

Media Digest (5/11/2012) Reuters, WSJ, NYT, FT, Bloomberg

Facebook’s initial public offering is already oversubscribed. (Reuters) JP Morgan (NYSE: JPM) books a $2 billion trading loss, and the figure could rise by another $1 billion. (Reuters) China’s industrial production and…

Douglas A. McIntyre